Press Release|

SHL Group announces new joint venture

Shl Group Joint Venture With Connectmesmart1 800x480

SHL Group is pleased to announce a new joint venture (JV) called “SHL Connect” between SHL Group and ConnectMeSmart GmbH.

The primary objective for SHL Connect is to investigate the market for connectivity and emerging technologies and explore their potential application within each of SHL Group’s companies.

Commenting on the announcement Roger Samuelsson, President and CEO of SHL Group, said: “The world around us is evolving at an incredible pace. More and more people are embracing technology as part of their daily lives, and we see some exciting opportunities for the customers and end-users of our products in building a more connected community. This JV will help us stay up to date with technological advances so that we can continue offering best in class products and services.”

The miniaturization and reduction in the cost of technology are producing a wave of products that are more interactive, more engaging, and more informative. SHL sees an opportunity to generate value for stakeholders by partnering with companies like ConnectMeSmart who have experience in these fields.

“Based on my experience working with NFC, Bluetooth Low Energy, and iBeacon connectivity in packaging and merchandising solutions, there are some exciting opportunities when it comes to new, low-cost sensors, smart technology, and data analytics. I’m looking forward to exploring these and other technologies and their potential applications within SHL Group,” says Markus Bauss, CEO of ConnectMeSmart.

In an effort to streamline customer communication, SHL Connect will coordinate directly with SHL’s global business development teams – providing regular updates on their activities. This approach enables partners from all business units to discuss potential connectivity projects through their existing contact windows.

Markus Bauss will be presenting on behalf of SHL Connect at Management Forum’s “Connectivity in Medical Technology” conference held at The Rembrandt Hotel, London on June 24-25, 2015.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News